US Stock MarketDetailed Quotes

AXSM Axsome Therapeutics

Watchlist
  • 73.630
  • +1.120+1.54%
Close Jun 14 16:00 ET
  • 74.230
  • +0.600+0.81%
Post 16:17 ET
3.50BMarket Cap-11415P/E (TTM)

Axsome Therapeutics Key Stats

Axsome Therapeutics Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

May 6, 2024

Revenue(YoY)

75.00M

-20.70%
EPS(YoY)

-1.44

-453.85%

Strong Buy

Jun 11, 2024

Axsome Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 99.980M--
--2024/Q2-- / 86.854M--
May 6, 20242024/Q174.999M / 72.852M--
Feb 20, 20242023/Q471.531M / 69.036M--
Nov 6, 20232023/Q357.794M / 54.860M--
Aug 7, 20232023/Q246.700M / 40.948M--
May 8, 20232023/Q194.576M / 26.319M--
Feb 27, 20232022/Q424.372M / 21.748M--
Nov 7, 20222022/Q316.846M / 17.057M--
Aug 9, 20222022/Q28.820M / 6.919M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 99.980M--
--2024/Q2-- / 86.854M--
May 6, 20242024/Q174.999M / 72.852M--
Feb 20, 20242023/Q471.531M / 69.036M--
Nov 6, 20232023/Q357.794M / 54.860M--
Aug 7, 20232023/Q246.700M / 40.948M--
May 8, 20232023/Q194.576M / 26.319M--
Feb 27, 20232022/Q424.372M / 21.748M--
Nov 7, 20222022/Q316.846M / 17.057M--
Aug 9, 20222022/Q28.820M / 6.919M--

Unlock Free Earnings Estimates

Axsome Therapeutics Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Jun 11, 2024

Strong Buy

  • Buy

    90.91%
  • Hold

    9.09%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg